Skip to main content
. 2023 Jan;29(1):226–228. doi: 10.3201/eid2901.221514

Table. Participant characteristics from a rapid SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji, November–December 2021.

Characteristics No. (%)* No. seropositive† Seroprevalence, % (95% CI)
Total
539
515
95.5 (93.4–97.1)
Sex
M 255 (47.3) 246 96.5 (93.2–98.3)
F
284 (52.7)
269
94.7 (91.3–97.0)
Age, years
8–11 51 (9.5) 36 70.6 (56.0–82.1)
12–17 73 (13.5) 66 90.4 (80.7–95.7)
18–29 132 (24.5) 132 100 (96.5–100)
30–39 143 (26.5) 141 98.6 (94.5–99.8)
40–49 96 (17.8) 96 100 (95.2–100)
>50
44 (8.2)
44
100 (90.0–100)
Ethnicity
I-Taukei 269 (49.9) 259 96.3 (93.1–98.1)
Fijian of Indian descent 249 (46.2) 236 94.8 (91.0–97.1)
Fijian of other descent
21 (3.9)
20
95.2 (74.1–99.8)
Occupation industry
Healthcare worker 158 (29.3) 157 99.4 (96.0–99.9)
Student 142 (26.3) 120 84.5 (77.3–89.8)
Transportation 94 (17.4) 94 100 (95.1–100)
Hotel 69 (12.8) 69 100 (93.4–100)
Education 40 (7.4) 39 97.5 (85.7–99.9)
Hospitality
36 (6.7)
36
100 (88.0–100)
COVID-19 vaccine status
None 76 (14.1) 58 76.3 (64.9–85.0)
1 dose 20 (3.7) 16 80.0 (55.7–93.4)
2 doses
443 (82.2)
441
99.5 (98.2–99.9)
Self-reported previous COVID-19
No 410 (76.1) 387 94.4 (91.6–96.3)
Yes 117 (21.7) 117 100 (96.0–100)
Unknown 12 (2.2) 11 91.7 (59.7–99.6)

*Percentage of total. †Number seropositive for SARS-CoV-2.